Effect of temozolomide on the U-118 glioma cell line

By Carmo A.   Carvalheiro H.   Crespo I.   Nunes I.   Lopes M. C.  

Oncology Letters, Vol. 2, Iss. 6, 2011-11 ,pp. : 1165-1170

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl2 pathway

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1951-1955

Spandidos Publications

Access to resources Recommend Favorite

Specific mTOR inhibitor rapamycin enhances cytotoxicity induced by alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in human U251 malignant glioma cells

By Tanaka Kazuhiro   Sasayama Takashi   Mizukawa Katsu   Kawamura Atsufumi   Kondoh Takeshi   Hosoda Kohkichi   Fujiwara Toshiyoshi   Kohmura Eiji  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 233-244

Springer Publishing Company

Access to resources Recommend Favorite

The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells

By Hayashi Takuro   Adachi Kazuhide   Ohba Shigeo   Hirose Yuichi  

Journal of Neuro-Oncology, Vol. 115, Iss. 2, 2013-11 ,pp. : 169-178

Springer Publishing Company

Access to resources Recommend Favorite

NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells

By                

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2586-2590

Spandidos Publications

Access to resources Recommend Favorite